- Home
- BTCT vs BEAT Comparison
BTCT vs BEAT Comparison
Compare BTCT & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTCT | BEAT |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9M | 27.7M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BTCT | BEAT |
|---|---|---|
| Price | $1.08 | $0.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | ★ 2.7M | 361.5K |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.07 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.58 | N/A |
| Revenue Next Year | N/A | $1,197.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.43 | $0.36 |
| 52 Week High | $3.12 | $4.00 |
Technical Indicators
Market Signals| Indicator | BTCT | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 45.00 | 34.64 |
| Support Level | $1.13 | N/A |
| Resistance Level | $1.24 | $0.52 |
| Average True Range (ATR) | 0.14 | 0.03 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 12.50 | 12.45 |
Price Performance
Historical ComparisonAbout BTCT BTC Digital Ltd.
BTC Digital Ltd is the ledger technology that underlies bitcoin and other cryptocurrencies, based in the U.S., with a focus on bitcoin mining. A blockchain is a decentralized, distributed, and encrypted digital public ledger that stores information in a secure, verifiable, and permanent way. The company also generates revenue through the resale of mining machines, mining machine rental, and miner hosting services.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.